Subcutaneous electrode and lead with phoresis based pharmacological agent delivery

US7702399B2 · kind B2 · utility

Assignee

• Cardiac Pacemakers, Inc. · US

Inventors

• Ron Heil · Roseville, US
• Paul A. Haefner · Circle Pines, US
• Adam Cates · Minneapolis, US
• Darrell Wagner · Isanti, US
• Curtis Lindstrom · Roseville, US

Key dates

• Filing date: Dec 4, 2003
• Grant date: Apr 20, 2010
• Expiry date: Jan 2, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61N1/36542
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

An implantable subcutaneous device includes a lead and electrode for cardiac monitoring and intervention. The device has an implantable lead including a lead body, a subcutaneous electrode supported by the lead body and a pharmacological agent impelled from the device using phoresis. The pharmacological agent provides a therapeutic treatment to subcutaneous non-intrathoracic tissue. A method of implanting subcutaneous leads involves providing a lead including a lead body, a subcutaneous electrode, and a pharmacological agent and using phoresis to impel the pharmacological agent into subcutaneous non-intrathoracic tissue surrounding the lead.